“Pay to Prescribe”: A Case for Strengthened Enforced of the FCPA in the Global Pharmaceutical Industry in 2017 and Beyond
John T. Jessee
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Rheology in the Pharmaceutical Industry
Kevin Barber • Oct 24, 2017
The Global Change in the Telecom Industry - - a Taiwan Case
Dr. Mao Chi - Kuo • Sep 28, 2017
M&A in Pharmaceutical Industry: Latest Trends M&A in global pharmaceutical market: latest developments
Nov 02, 2017